Insmed (INSM) Gross Margin (2018 - 2026)
Insmed's Gross Margin came in at 84.20% for Q2 2026, up 10.34 percentage points from 73.86% a year earlier but down 0.30 percentage points from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Gross Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Insmed reported Gross Margin of 83.46%, up 7.74 percentage points year-over-year; for FY2025, it came in at 79.73%, up 3.30 percentage points from FY2024.
- Gross Margin carries a five-year change of +3.98 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 76.43% in FY2024 (-2.09 pp), 78.52% in FY2023 (+0.98 pp), 77.53% in FY2022 (+0.96 pp) and 76.57% in FY2021 (+0.82 pp).
- The five-year range for quarterly Gross Margin is 73.86% (Q2 2025) to 84.50% (Q1 2026).
- Year-over-year, Gross Margin has increased for four consecutive quarters, with an average year-over-year change of +2.60 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2026 (a gain of 10.34 percentage points), and the weakest in Q4 2024 (a drop of 3.00 percentage points).
- Business Quant data shows INSM's Gross Margin at 84.50% (Q1 2026), 83.24% (Q4 2025) and 79.37% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | 85.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 85.09% |
| Jun 30, 2026 | 84.20% |
| Mar 31, 2026 | 84.50% |
| Dec 31, 2025 | 83.24% |
| Sep 30, 2025 | 79.37% |
| Jun 30, 2025 | 73.86% |
| Mar 31, 2025 | 77.08% |
| Dec 31, 2024 | 74.96% |
| Sep 30, 2024 | 77.34% |
| Jun 30, 2024 | 76.79% |
| Mar 31, 2024 | 76.88% |
| Dec 31, 2023 | 77.96% |
| Sep 30, 2023 | 78.87% |
| Jun 30, 2023 | 78.51% |
| Mar 31, 2023 | 78.79% |
| Dec 31, 2022 | 77.96% |
| Sep 30, 2022 | 80.11% |
| Jun 30, 2022 | 74.86% |
| Mar 31, 2022 | 77.04% |
| Dec 31, 2021 | 76.32% |
API Access
Insmed Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();